A stem cell transplant for multiple myeloma depends on many factors. Dr. Saad Z. Usmani, a leading myeloma expert at Memorial Sloan Kettering Cancer Center, breaks down how treatment typically unfolds and explains why these decisions are often highly personalized. His insights help patients better understand when a transplant may be recommended, and when it […]

When you learn that you have a multiple myeloma diagnosis, your care team may discuss something called an ACST, which is an acronym for an “autologous stem cell transplant.” This is a common treatment option for many people with multiple myeloma. Let’s explore what this type of stem cell treatment is and how it might […]

Every year, the American Society of Hematology (ASH) gathers experts from around the world to share the latest research in blood cancers. At the 2025 meeting, several studies revealed promising findings for patients with multiple myeloma, from early-stage interventions to advanced treatment options. These results highlight ways to improve outcomes, manage side effects, and explore […]